Matt & Mark Discuss AccessCMD
Join Matt Wilson and Mark Toshner as they discuss AccessCMD, uMed's Cardiometabolic cohort. An Interactive Cardiometabolic Disease registry with research-consented patients.
Related articles
Continue reading
.png)
Company News
Partners
May 11, 2026
uMed and Cera partner to bring clinical research to the point of care.
Expanding trial recruitment to a long-underserved 65+ cohort.
Read more
Company News
Partners
October 30, 2025
Partnering with WellSky to expand the reach of real-world data
Read more
Company News
Product
May 1, 2025
uMed Launches SnapACCESS: A Groundbreaking Solution for Agile and Compliant Patient Data Insights in Diabetes and Obesity Research
Read more
Book a complimentary demonstration.
For a clear picture of how uMed could work for you, book a free session with our team.
hello@umed.io
hello@umed.io
